Michael Jewett

Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

Princess Margaret Cancer Centre treats both inpatients and outpatients in the cancer program. Its amenities include food and retail services, internet, phone & television, information, security and lost & found, activities & relaxation, patient & family library, child care and princess Margaret lodge. The firm’s patient and family services include spiritual care, health information & patient education, accounts receivable, health records and pharmacy. The company was founded in 1952 and is headquartered in Toronto, Canada.